DocGo Reports Q3 2026 Revenue Growth and Improved Adjusted EBITDA Losses
DocGo (DCGO) reported third-quarter revenue of $73.4 million, a 4% increase driven by core transportation market growth and the integration of SteadyMD. While the company still faces an adjusted EBITDA loss of $3.2 million, this represents significant sequential improvement from losses in both Q1 and Q2. The company is actively optimizing its portfolio, which includes exiting underperforming business lines and winding down operations in Upstate New York to focus on higher-margin segments. Operational efficiencies are improving through the use of AI voice agents, which helped reduce in-home visit costs per booking by over 50%. Despite a slight reduction in unrestricted cash to $19.1 million, DocGo secured $12.5 million in debt financing from Perceptive Advisors and expects further funding following the upcoming Hicuity Health acquisition. Management has revised full-year revenue guidance slightly downward to approximately $300 million as they prioritize profitability over low-margin volume.
Tickers: $DCGO
Topics: EBITDA loss guidance revision medical transportation mobile health revenue growth